Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
NDRA
NDRA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NDRA News
Danaher Exceeds Q4 Earnings Guidance but Faces Market Skepticism
Jan 28 2026
CNBC
ENDRA Launches Low-Cost TAEUS Liver Detection Technology Under $200
Dec 04 2025
Newsfilter
ENDRA Life Sciences Reveals At-Market Private Placement Opportunity of Up to $14.4 Million
Oct 13 2025
SeekingAlpha
Ascendiant Capital Reaffirms Buy Rating on ENDRA Life Sciences, Adjusts Price Target to $38
Sep 22 2025
Benzinga
Gold Falls 1%; ProKidney Shares Spike Higher
Jul 08 2025
Benzinga
US Stocks Mixed; Small Business Sentiment Falls In June
Jul 08 2025
Benzinga
Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket
Jul 08 2025
Benzinga
Microchip Technology To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Friday
May 30 2025
Benzinga
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $46
May 30 2025
Benzinga
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Apr 23 2025
Benzinga
Ascendiant Capital Maintains Buy on ENDRA Life Sciences, Lowers Price Target to $50
Apr 21 2025
Benzinga
ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies
Mar 31 2025
Newsfilter
ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
Nov 22 2024
Newsfilter
ENDRA Life Sciences Reports Q3 2024 Results and Progress
Nov 16 2024
Business Insider
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
Nov 15 2024
Newsfilter
ENDRA Life Sciences Inc trading halted, news pending
Nov 06 2024
Business Insider
Show More News
